A trial of Human Cytomegalovirus Immunoglobulin (pH4).
Phase of Trial: Phase I
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Cytomegalovirus immune globulin (Primary)
- Indications Cytomegalovirus infections
- Focus Adverse reactions
- 02 Mar 2017 New trial record
- 23 Feb 2017 According to a China Biologic media release, company received CFDA approvals to commence this trial.